SEC Form D private-offering filing
CytoDyn Inc.
A new SEC Form D private-offering notice from Vancouver, WA, a $18,600,392 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biotechnology company developing leronlimab, a CCR5 targeting monoclonal antibody, for oncology and other therapeutic indications.
Filed 2026-05-11Filed to raise $18,600,392First money in 2026-01-30Raised so far $18,600,392HQ (as filed) Vancouver, WASector Biotech ✓Stage (inferred) EarlyCall status Needs classification
Source linked the Form D on EDGAR↗Website verified cytodyn.com↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.